Patients with DLB show either normal levels of these core CSF biomarkers or slightly elevated T-tau and slightly decreased Aβ42, while P-tau levels are around normal or only slightly elevated or slightly decreased. This evidence concerns the gene MAPT and Lewy body dementia.